No data to show
OTCM
CANQF
Market cap241kUSD
Jul 21, Last price
0.01USD
1D
0.00%
Jan 2017
-97.93%
IPO
-99.25%
Name
CanaQuest Medical Corp
Chart & Performance
P/E
—
P/S
9.71
EPS
—
Div Yield, %
—
Shrs. gr., 5y
8.64%
Rev. gr., 5y
%
Revenues
34k
Net income
-1m
L+66.40%
CFO
-273k
L-44.01%
Profile
CanaQuest Medical Corp. develops health products and pharmaceuticals that utilize hemps, cannabis, and algae oils. The company was formerly known as Algae Dynamics Corp. and changed its name to CanaQuest Medical Corp. in January 2019. CanaQuest Medical Corp. was founded in 2008 and is based in Mississauga, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2018‑03 | 2017‑03 | 2016‑03 | |
| Income | ||||||||
Revenues | 34 | |||||||
Cost of revenue | 62 | 31 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | (28) | (31) | ||||||
NOPBT Margin | ||||||||
Operating Taxes | 4 | |||||||
Tax Rate | ||||||||
NOPAT | (28) | (31) | ||||||
Net income | (1,386) 66.40% | (833) 39.47% | ||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 459 | 222 | ||||||
BB yield | -21.63% | -5.97% | ||||||
| Debt | ||||||||
Debt current | 376 | 635 | ||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | 376 | 635 | ||||||
| Cash flow | ||||||||
Cash from operating activities | (273) | (488) | ||||||
CAPEX | 1 | |||||||
Cash from investing activities | ||||||||
Cash from financing activities | 269 | 474 | ||||||
FCF | 327 | 2 | ||||||
| Balance | ||||||||
Cash | 78 | |||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | (5,753) | (4,929) | ||||||
Invested Capital | 5,022 | 4,557 | ||||||
ROIC | ||||||||
ROCE | 3.85% | 8.36% | ||||||
| EV | ||||||||
Common stock shares outstanding | 21,211 | 20,656 | ||||||
Price | 0.10 -44.44% | 0.18 -40.00% | ||||||
Market cap | 2,121 -42.95% | 3,718 -40.00% | ||||||
EV | 2,497 | 4,353 | ||||||
EBITDA | (8) | (31) | ||||||
EV/EBITDA | ||||||||
Interest | 68 | 62 | ||||||
Interest/NOPBT | ||||||||